Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression
- PMID: 9458167
- PMCID: PMC8098321
- DOI: 10.1111/j.1750-3639.1998.tb00136.x
Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression
Abstract
The role of glial inflammatory processes in Alzheimer's disease has been highlighted by recent epidemiological work establishing head trauma as an important risk factor, and the use of anti-inflammatory agents as an important ameliorating factor, in this disease. This review advances the hypothesis that chronic activation of glial inflammatory processes, arising from genetic or environmental insults to neurons and accompanied by chronic elaboration of neuroactive glia-derived cytokines and other proteins, sets in motion a cytokine cycle of cellular and molecular events with neurodegenerative consequences. In this cycle, interleukin-1 is a key initiating and coordinating agent. Interleukin-1 promotes neuronal synthesis and processing of the beta-amyloid precursor protein, thus favoring continuing deposition of beta-amyloid, and activates astrocytes and promotes astrocytic synthesis and release of a number of inflammatory and neuroactive molecules. One of these, S100beta, is a neurite growth-promoting cytokine that stresses neurons through its trophic actions and fosters neuronal cell dysfunction and death by raising intraneuronal free calcium concentrations. Neuronal injury arising from these cytokine-induced neuronal insults can activate microglia with further overexpression of interleukin-1, thus producing feedback amplification and self-propagation of this cytokine cycle. Additional feedback amplification is provided through other elements of the cycle. Chronic propagation of this cytokine cycle represents a possible mechanism for progression of neurodegenerative changes culminating in Alzheimer's disease.
Similar articles
-
Glial cytokines in Alzheimer's disease: review and pathogenic implications.Hum Pathol. 1995 Aug;26(8):816-23. doi: 10.1016/0046-8177(95)90001-2. Hum Pathol. 1995. PMID: 7635444 Free PMC article. Review.
-
The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus.J Neurovirol. 1997 Aug;3(4):241-6. doi: 10.3109/13550289709029465. J Neurovirol. 1997. PMID: 9291232 Review.
-
The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.Neurobiol Aging. 2001 Nov-Dec;22(6):915-22. doi: 10.1016/s0197-4580(01)00293-7. Neurobiol Aging. 2001. PMID: 11754999 Review.
-
Deleterious Alteration of Glia in the Brain of Alzheimer's Disease.Int J Mol Sci. 2020 Sep 12;21(18):6676. doi: 10.3390/ijms21186676. Int J Mol Sci. 2020. PMID: 32932623 Free PMC article. Review.
-
Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo.Neurobiol Aging. 2004 Nov-Dec;25(10):1283-92. doi: 10.1016/j.neurobiolaging.2004.01.006. Neurobiol Aging. 2004. PMID: 15465624
Cited by
-
Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.F1000Res. 2020 May 11;9:345. doi: 10.12688/f1000research.23729.1. eCollection 2020. F1000Res. 2020. PMID: 32704352 Free PMC article.
-
The role of TREM2 in Alzheimer's disease: from the perspective of Tau.Front Cell Dev Biol. 2023 Nov 8;11:1280257. doi: 10.3389/fcell.2023.1280257. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38020891 Free PMC article. Review.
-
Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.Neurobiol Dis. 2010 Jun;38(3):482-91. doi: 10.1016/j.nbd.2010.01.019. Epub 2010 Feb 10. Neurobiol Dis. 2010. PMID: 20149872 Free PMC article.
-
IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.Sci Rep. 2018 Aug 13;8(1):12050. doi: 10.1038/s41598-018-30487-6. Sci Rep. 2018. PMID: 30104698 Free PMC article. Review.
-
Translational research on the way to effective therapy for Alzheimer disease.Arch Gen Psychiatry. 2005 Nov;62(11):1186-92. doi: 10.1001/archpsyc.62.11.1186. Arch Gen Psychiatry. 2005. PMID: 16275806 Free PMC article. Review.
References
-
- Abe K, Tanzi RE, Kogure K (1991) Selective induction of Kunitz‐type protease inhibitor domain containing β‐APP mRNA after persistent focal ischaemia in rat cerebral cortex. Neurosci Lett 125: 172–74. - PubMed
-
- Allore R, O'Hanlon D, Price R, Neilson K, Willard HF, Cox DR, Marks A, Dunn RJ (1988) Gene encoding the β subunit of S100 protein is on chromosome 21: Implications for Down syndrome. Science 239: 1311–13. - PubMed
-
- Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A (1995) Do nonsteroidal anti‐inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 45: 1441–1445. - PubMed
-
- Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878–881. - PubMed
-
- Barger SW, Van Eldik LJ (1992) S100β stimulates calcium fluxes in glial and neuronal cells. J Biol Chem 267: 9689–94. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical